More Genfleet Therapeutics (Shanghai), Inc. news
Genfleet Therapeutics (Shanghai), Inc.HKEX: 2595

Next Day Disclosure Return

Oct 13, 2026 at 6:58 AM EDT · Issued by Genfleet Therapeutics (Shanghai), Inc. via HKEXnews

Filed with HKEX · Stock code 2595 · Oct 13, 2026 at 6:58 AM EDT · 6 pages · English

On 6ix: 6ix.com/news/next-day-disclosure-return-942

Genfleet Therapeutics (Shanghai), Inc. on 6ix

Earlier from Genfleet Therapeutics (Shanghai)

  • Monthly Return of Equity Issuer on Movements in Securities for the Month Ended 30 September 2026Oct 5
  • List of directors and their roles and functionsSep 24
  • Resignation of non-executive directorSep 24
  • VOLUNTARY ANNOUNCEMENT Disclosure Arrangements for Clinical Data from Studies of GFH375 and GFH276Sep 23
  • Announcement pursuant to rule 13.10 of the listing rulesSep 22

Later from Genfleet Therapeutics (Shanghai)

  • VOLUNTARY ANNOUNCEMENT GFH375/VS-7375 (Oral KRAS G12D Inhibitor) Achieves Positive Progress across Multiple Clinical Studies in China and Abroad, with Promising Efficacy in Various RAS-mutant Solid TumorsOct 15
All Genfleet Therapeutics (Shanghai) news releases↗

Follow Genfleet Therapeutics (Shanghai) into a list and get an email when it puts out news.

Follow Genfleet Therapeutics (Shanghai)
  • About 6ix
  • Editorial & Sourcing
  • Corrections
  • Contact
  • Privacy
  • Terms
  • Disclaimer